Your browser doesn't support javascript.
loading
B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis.
Biewenga, Maaike; Heidt, Sebastiaan; Vergunst, Manon; Marijnissen, Camiel M J; de Man, Rob A; van der Eijk, Annemiek A; van der Meer, Adriaan J; Trouw, Leendert A; van Hoek, Bart.
Afiliación
  • Biewenga M; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
  • Heidt S; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
  • Vergunst M; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
  • Marijnissen CMJ; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
  • de Man RA; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van der Eijk AA; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van der Meer AJ; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Trouw LA; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Hoek B; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
JHEP Rep ; 4(5): 100460, 2022 May.
Article en En | MEDLINE | ID: mdl-35368991

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: JHEP Rep Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: JHEP Rep Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos